Clinical Trials Browser

Phase 2 × Completed × Carcinoma, Basal Cell × Clear all

NCT00833417 2026-05-11

A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma

Phase 2 Completed

104 enrolled 13 charts

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT00959647 2026-05-08

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Phase 2 Completed

19 enrolled 10 charts

DermatologicGastrointestinalGynecologic

Carcinoma, Basal Cell, Ovarian Neoplasms, Colorectal Neoplasms

NCT06608238 2026-05-04

Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.

Phase 2 Completed

Carcinoma, Basal Cell

NCT02667574 2026-04-22

VISMONEO

Phase 2 Completed

Carcinoma, Basal Cell

NCT03534947 2025-12-16

SONIB

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms

NCT05188729 2025-06-18

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Phase 2 Completed

92 enrolled 17 charts

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Skin Neoplasms

NCT04552990 2025-04-23

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT03132636 2025-04-08

PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

Phase 2 Completed

138 enrolled 21 charts 1 FDA

Carcinoma, Basal Cell

NCT04893486 2024-08-29

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT04416516 2024-04-10

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT04669808 2024-03-18

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT03546166 2023-07-21

PICABAS

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

NCT05315128 2022-04-07

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

Phase 2 Completed

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratoacanthoma

NCT03035188 2022-02-11

NICCI

Phase 2 Completed

Carcinoma, Basal Cell

NCT03180528 2021-06-08

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Phase 2 Completed

30 enrolled 10 charts

Carcinoma, Basal Cell

NCT01556009 2020-11-02

Vismodegib

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Phase 2 Completed

36 enrolled 7 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT03714529 2020-10-08

A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT02354261 2020-08-05

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Phase 2 Completed

Carcinoma, Basal Cell

NCT02762084 2020-07-23

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase 2 Completed

17 enrolled 22 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01327053 2019-08-28

BOLT

Phase 2 Completed

230 enrolled 26 charts

Carcinoma, Basal Cell, Skin Neoplasms

NCT01367665 2019-06-06

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Phase 2 Completed

1,232 enrolled 19 charts

Carcinoma, Basal Cell

NCT01700049 2019-05-23

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Phase 2 Completed

28 enrolled 9 charts

Carcinoma, Basal Cell

NCT02828111 2019-01-08

BCC

Phase 2 Completed

36 enrolled 17 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01108094 2018-11-13

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

Phase 2 Completed

29 enrolled 13 charts

Carcinoma, Basal Cell, Skin Neoplasms

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Phase 2 Completed

DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

NCT01815840 2017-09-28

A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

Phase 2 Completed

229 enrolled 18 charts

Carcinoma, Basal Cell

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Phase 2 Completed

34 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00089180 2015-12-04

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT00961896 2015-11-03

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase 2 Completed

18 enrolled 13 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01350115 2015-10-19

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase 2 Completed

10 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00108121 2015-01-19

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT01358045 2015-01-13

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT01543581 2014-09-26

Erivedge

Phase 2 Completed

3 enrolled 5 charts

Carcinoma, Basal Cell

NCT01201915 2014-06-24

A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma

Phase 2 Completed

74 enrolled 7 charts

Carcinoma, Basal Cell

NCT00002975 2013-10-10

Photodynamic Therapy in Treating Patients With Skin Cancer

Phase 2 Completed

180 enrolled 3 charts

DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

NCT00023621 2013-06-26

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Phase 2 Completed

Carcinoma, Basal Cell

NCT00002963 2013-01-31

Photodynamic Therapy in Treating Patients With Skin Cancer

Phase 2 Completed

Carcinoma, Basal Cell

NCT00586040 2009-04-10

PTB

Phase 2 Completed

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Dysplastic Nevus Syndrome, Skin Neoplasms

NCT00108134 2008-12-24

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT00188370 2005-09-16

Ultrasound Biomicroscopy - Apoptosis

Phase 2 Completed

DermatologicLymphoid

Carcinoma, Basal Cell, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma